Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Femasys IncCommon Stock (FEMY) stocks in Canada

Learn how to easily invest in Femasys IncCommon Stock stocks.

Femasys IncCommon Stock is a medical instruments & supplies business based in the US. Femasys IncCommon Stock stocks (FEMY.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $7.2 – a decrease of 0.71% over the previous week. Femasys IncCommon Stock employs 24 staff and has a trailing 12-month revenue of around $1.2 million.

How to buy shares in Femasys IncCommon Stock

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – FEMY – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Femasys IncCommon Stock stock price (NASDAQ:FEMY)

Use our graph to track the performance of FEMY stocks over time.

Femasys IncCommon Stock shares at a glance

Information last updated 2022-01-26.
Latest market close$2.79
52-week range$2.61 - $13.75
50-day moving average $4.33
200-day moving average $6.42
Wall St. target price$21.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.71

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Femasys IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Femasys IncCommon Stock price performance over time

Historical closes compared with the close of $2.79 from 2022-01-27

1 week (2022-01-21) -0.71%
1 month (2021-12-29) -20.06%
3 months (2021-10-29) -59.74%
6 months (2021-07-29) -61.52%
1 year (2021-01-25) N/A
2 years (2020-01-25) N/A
3 years (2019-01-25) N/A
5 years (2017-01-25) N/A

Femasys IncCommon Stock financials

Revenue TTM $1.2 million
Gross profit TTM $731,385
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value $2.43
Market capitalisation $35.8 million

TTM: trailing 12 months

Femasys IncCommon Stock share dividends

We're not expecting Femasys IncCommon Stock to pay a dividend over the next 12 months.

Femasys IncCommon Stock overview

Femasys Inc. , a biomedical company, researches, develops, and manufactures medical devices for the women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a sterile, single-use disposable endocervical curettage product; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site